$0.56 0.00 (0.64%) CytRx Corp - NASDAQ

Sep. 27, 2016 | 04:00 PM
Last Trade: 0.56
Trade Time: Sep 27 04:00 PM Eastern Daylight Time
Change: +0.00 (0.64%)
Prev Close: 0.56
Open: 0.56
Bid: 0.56
Ask: 0.56
  1. No results found.
  1. Aldoxorubicin Continues To Demonstrate Positive Clinical Activity In Phase 2 Glioblastoma Trial

    Benzinga | Nov. 23, 2015 | 09:00AM EST
  2. Mid-Morning Market Update: Markets Open Higher; Lennar Tops Q3 Views

    Benzinga | Sep. 21, 2015 | 10:29AM EST
  3. CytRx Announces the Publication of its Positive Global Phase 2b Clinical Trial Results for Soft Tissue Sarcoma in the Peer-Reviewed JAMA Oncology

    Benzinga | Sep. 21, 2015 | 09:02AM EST
  4. CytRx Announces the Presentation of its Phase 2b Clinical Trial Design in Small Cell Lung Cancer at the World Conference on Lung Cancer in Denver, Colorado

    Benzinga | Sep. 3, 2015 | 09:02AM EST
  5. Mid-Day Market Update: Dow Dips Over 1%; Harley-Davidson Shares Rise On Earnings Beat

    Benzinga | Jul. 21, 2015 | 12:46PM EST
  6. CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer)

    Benzinga | May. 21, 2015 | 09:03AM EST
  7. Tuesday's Morning Movers: FXCM Takes Another Big Drop

    Benzinga | Jan. 20, 2015 | 09:44AM EST
  8. Aegis Capital Reiterates Buy On CytRx As Stock Soars 17%

    Benzinga | Jan. 6, 2015 | 15:20PM EST
  9. Mid-Morning Market Update: Markets Open Higher; Commercial Metals Posts Upbeat Earnings

    Benzinga | Jan. 6, 2015 | 10:46AM EST
  10. Tuesday's Morning Market Movers: Minerva, El Pollo LoCo And More

    Benzinga | Jan. 6, 2015 | 10:42AM EST
  11. Morning Market Movers

    Benzinga | Jan. 6, 2015 | 09:50AM EST
  12. Mid-Morning Market Update: Markets Gain; Pacific Ethanol Reports Merger Deal With Aventine Renewable Energy

    Benzinga | Dec. 31, 2014 | 10:31AM EST
  13. CytRx Receives Written FDA Communication Regarding Partial Clinical Hold for Aldoxorubicin Clinical Trials

    Benzinga | Dec. 3, 2014 | 06:05AM EST
  14. Morning Market Losers

    Benzinga | Nov. 18, 2014 | 09:52AM EST
  15. CytRx Announces Publication of Phase 1b/2 Aldoxorubicin Clinical Data In Soft Tissue Sarcoma In Cancer, The Peer-Reviewed Journal Of The American Cancer Society

    Benzinga | Oct. 20, 2014 | 06:04AM EST
Trading Center